Chronic Telogen Effluvium: Recovery Timeline & Treatments

Medically reviewed by our internal panel of dermatology experts.

---

Sophie came to see me last November. Thirty-eight years old. Interior designer. She arrived with a folder — a real, cardboard binder — that held eighteen months of photos taken on the first of every month, a list of four dermatologists consulted, and six pages of bloodwork.

“They all tell me my labs are normal,” she said as she set the folder down. “But I’ve been losing my hair for a year and a half. I have no ponytail left. I avoid showers. And nobody understands what I’m going through.”

I took the folder. Flipped three pages. Ferritin at 28 ng/mL — flagged “normal” by the lab because it was above 20. TSH at 3.8 — “normal” because under 4.5. Vitamin D at 19 — flagged “borderline.” Every marker was deep in the follicular red zone, but no general practitioner had connected the dots.

This is the most common story I see in consultation: a woman shedding hair for more than six months, told it’s “just stress,” whose bloodwork has never been read with the right thresholds in mind.

What she had has a precise name: chronic telogen effluvium (CTE). Diffuse shedding that lasts beyond six months with no spontaneous resolution. One of the most misdiagnosed entities in general medicine, and one of the most distressing for the women living through it — because it creates that very specific sensation of slowly draining your hair capital, with no precise target, no explanation.

Here is what nine years of follow-up taught me to tell my CTE patients. The exact mechanism. How to differentiate it from early FPHL. The bloodwork nobody requests properly. And the three-phase recovery protocol that, in the majority of my cases, brings back a stable, dense head of hair in 9 to 12 months.

Chronic telogen effluvium: the definition no one gives you in clinic

Chronic telogen effluvium is a precise clinical entity, first defined by Whiting in 1996 in the Journal of the American Academy of Dermatology. Three criteria make the diagnosis:

• Diffuse shedding across the entire scalp (not localized like FPHL)
• Duration over 6 months, with no tendency toward spontaneous resolution
• Absence of follicular miniaturization on trichoscopy (hair shaft diameter preserved)

That last criterion is the crucial one. And it’s what radically distinguishes CTE from female pattern hair loss (FPHL), even though the two can coexist in the same woman — which further complicates the diagnosis.

What’s really happening inside your follicle

To understand CTE, you have to visualize the normal hair cycle. Your follicles don’t shed all at once — fortunately. They operate in an asynchronous mosaic: at any given moment, 85% of your hairs are in anagen phase (growth, 2 to 6 years), 1% in catagen (transition, 2 to 3 weeks), and 14% in telogen (rest then shedding, 2 to 3 months).

In chronic telogen effluvium, this ratio flips. The anagen phase shortens abnormally — sometimes dropping from 4 years to 18 months — and the percentage of follicles in telogen climbs to 20, 25, sometimes 30%. Visible result: you shed far more hair daily, and what grows back has a shortened lifespan. The capital drains quietly.

This is exactly what my patients describe: “I feel like my hair doesn’t hold as long anymore.” It’s biologically true. It’s not just an impression.

Why the 6-month threshold is sacred

Under 6 months, you’re still in the window of an acute telogen effluvium — the kind that follows an identified trigger (childbirth, surgery, fever, massive weight loss, COVID, general anesthesia) and resolves spontaneously in 6 to 12 months. If your profile matches that case, read our dedicated guide on postpartum hair loss which covers the acute mechanism in detail.

Beyond 6 months without improvement, you cross into chronic territory — and the therapeutic strategy changes completely. You can’t just wait it out anymore. The shedding has become self-sustaining, the biological terrain is depleted, and you have to actively restart growth.

💡 Expert advice from Elena S.: “A patient, Helen, 42, a literature professor, once told me a phrase that stayed with me: ‘I’m not losing my hair in handfuls anymore, I’m losing it in slow waves — like a tide that never comes back in.’ That’s the most accurate metaphor for chronic effluvium I’ve ever heard. It’s not a spectacular collapse like postpartum. It’s a slow continuous leak that erodes your density without sending an alarm strong enough to mobilize doctors.”

Acute vs chronic vs FPHL: the differential diagnosis in 60 seconds

This is the question my patients ask first: “how do I know what I actually have?”. Here are the three entities to differentiate — because the treatments are radically different.

The sorting table

Criterion	Acute effluvium	Chronic effluvium	Early FPHL
Duration	< 6 months	≥ 6 months	Progressive, several years
Pattern	Diffuse	Diffuse	Crown, widening part
Trigger	Identifiable (2-4 months prior)	Often multifactorial	Hormonal/genetic
Miniaturization	Absent	Absent	Present
Evolution untreated	Spontaneous resolution	Persistence	Slow worsening
Follicular capital	Preserved	Preserved	Irreversibly reduced

The critical distinction for you: in chronic effluvium, your follicles are alive and functional. They just produce less hair. That’s excellent news — it means recovery is physiologically possible, you “just” have to correct the systemic environment slowing the anagen phase.

In FPHL, the follicle shrinks irreversibly. That’s an entirely different battle, requiring lifelong anti-androgenic treatments (minoxidil, spironolactone). Confusing the two means two years of inadequate treatment.

Assess your profile in 4 questions

Whatever your result, hold on to this principle: chronic telogen effluvium is almost always reversible — provided you identify the systemic cause(s) maintaining it. And it’s rarely a single cause. In 70% of my consultations, it’s a stack of multiple sub-deficiencies that would have been considered “normal” individually but become toxic in combination.

The 7 systemic causes that maintain chronic effluvium

Here are the seven triggers I systematically review with my CTE patients. None are dramatic in isolation. It’s their layering that creates the clinical picture.

1. Sub-optimal iron deficiency (the #1 under-diagnosed cause)

The most common and most poorly identified cause. A ferritin of 25 ng/mL gets labeled “normal” by your lab — because the official reference threshold is usually set at 15 or 20. But for the hair follicle, optimum sits above 70 ng/mL (Trost et al., 2006).

The hair follicle is one of the most iron-hungry tissues in your body. Keratin synthesis requires iron-dependent enzymes. When ferritin drops below 50, the follicle gets out-bid: the body prioritizes red blood cell production and shortens the anagen phase. Result: chronic effluvium that persists until stores are replenished.

Women of reproductive age often stack up risks: heavy periods, regular menstrual losses, sometimes poorly compensated vegetarianism, sometimes a recent pregnancy. Ferritin gradually collapses over three to five years, and the follicle lets go when the reservoir hits critical.

2. Subclinical thyroid dysfunction

Hashimoto thyroiditis and early hypothyroidism are massively under-diagnosed in adult women. And their first visible sign is almost always hair loss — well before fatigue, weight gain or cold intolerance. A TSH of 3.5 is called “normal” by labs (cutoff < 4.5), but the optimal capillary thyroid window sits between 0.5 and 2.5 mIU/L. Anything above 2.5 deserves anti-TPO antibody testing and an endocrinology referral.

3. Massive vitamin D deficiency

In Europe and the northern US, vitamin D deficiency affects 60 to 80% of women coming out of winter. Vitamin D receptors are expressed in the dermal papilla of the follicle — without it, the catagen-to-anagen transition doesn’t fire properly. Capillary optimum is above 50 ng/mL (Rasheed et al., 2013), while population median sits at 21.

4. Sustained chronic stress (>12 months)

Elevated cortisol over the long term inhibits anagen through multiple mechanisms — HPA axis dysregulation, perifollicular vasoconstriction, increased sensitivity to local 5α-reductase. A period of acute stress generates a reversible acute effluvium. A chronic stress lasting over 12 months keeps the follicle in prolonged telogen and flips it into CTE territory.

5. Caloric or protein restriction

Anagen requires 200 mg of keratin per day for the entire scalp. That’s a major energy expenditure. Any diet under 1400 kcal/day lasting more than 8 weeks, or any diet providing less than 60 g of protein per day, generates a famine signal that the follicle immediately interprets. Poorly calibrated vegetarianism is a frequent cause I see in women aged 30 to 45.

6. Hair-toxic medications

Many common medications trigger chronic effluvium. The must-know list: isotretinoin (Accutane), beta-blockers (notably propranolol), anticoagulants (heparin, warfarin), SSRIs, lithium, valproate, long-term proton pump inhibitors (omeprazole), high-androgenic-progestin birth control, immunosuppressants. If you’ve been on one of these for more than 6 months and your shedding coincides, raise it with your prescriber.

7. Post-viral infection (post-COVID notably)

Since 2021, I’ve been seeing a considerable volume of post-COVID chronic effluvium in clinic, sometimes 9 months or more after the initial infection. The mechanism likely involves prolonged immune dysregulation and low-grade scalp inflammation. Resolution timeline is longer than classic acute effluvium — count 12 to 18 months on a strict protocol.

💡 Expert advice from Elena S.: “One of my patients, Margot, 34, a journalist, came in saying: ‘I eat healthy, I sleep 7 hours, I do yoga, I don’t understand why I’m losing my hair.’ We ran her full panel. Ferritin 31. Vitamin D 16. TSH 3.2. Three stacked sub-deficiencies, none dramatic alone. Three months after targeted correction, her shedding had dropped 60%. No topical intervention. Just the right panel, read with the right thresholds.”

The EXACT bloodwork to request (and the capillary thresholds to demand)

This is the most important section of this article. If you remember one thing, it’s this: ask your doctor for this complete panel, and demand capillary thresholds, not lab thresholds.

The 8-point panel

Here’s the template I hand my patients before their first consultation:

• Ferritin — capillary optimum ≥ 70 ng/mL (not 15 as the lab says). Below 40, systematic supplementation
• Transferrin saturation coefficient — to rule out an overload anemia masking the real deficiency
• TSH — optimum between 0.5 and 2.5 mIU/L. Above that: free T4 + anti-TPO
• Vitamin D 25-OH — optimum ≥ 50 ng/mL. Below 30: high-dose supplementation (4000 IU/day)
• Vitamin B12 — optimum ≥ 400 pg/mL, especially in vegetarians
• Folate (vitamin B9) — optimum ≥ 5 ng/mL
• Serum zinc — optimum between 100 and 130 µg/dL. Often sub-optimal on restrictive diets
• 4-point salivary cortisol (only if HPA dysregulation suspected) — to map the diurnal stress curve

The traps no one mentions

Three frequent traps I see on the labs my patients bring in:

Trap 1: “normal” ferritin under inflammation. If you have chronic infection, autoimmune disease, or even silent inflammatory syndrome, ferritin can be falsely elevated. Always test CRP in parallel to interpret correctly.

Trap 2: high-dose biotin distorting TSH. If you take a hair supplement with more than 5000 µg of biotin per day, TSH measurement can be completely off (underestimated). Tell your lab and stop biotin 72h before the draw.

Trap 3: vitamin D testing in winter vs summer. Always run the panel coming out of winter (March-April) to capture the real minimum. A September panel will falsely reassure you.

The exact cost

In the US, count $200-400 for a complete out-of-pocket panel (most are covered if prescribed). Zinc and B12 are sometimes excluded. It’s a non-negotiable investment — without these numbers, you’re flying blind for months or years.

The 3-phase recovery protocol over 12 months

Once the bloodwork is in hand and any deficiencies identified, here’s the protocol I systematically structure for my CTE patients. Three phases, twelve months, with measurable goals at each stage.

Phase 1: Months 0-3 — Deficiency correction and stabilization

The goal of the first three months is not regrowth — it’s stopping the shedding. Targeted supplementation (iron bisglycinate if ferritin < 70, high-dose vitamin D if deficient, B complex if vegetarian) must bring biological parameters back to optimal capillary thresholds.

During this phase, we add topical rosemary officinalis essential oil with cineole, validated by the Panahi 2015 study as equivalent to 2% minoxidil at 6 months on mild androgenetic alopecia. On CTE, its vasodilatory action and effect on perifollicular microcirculation make it a valuable ally. Dilute to 2-3% in a carrier oil, apply 2 to 3 evenings per week. Our full review of Mielle rosemary oil details the exact application protocols.

Phase 2: Months 3-9 — Active anagen restart

This is the key phase. Once biological parameters are restored, we introduce the multi-peptide serum which acts directly on the dermal papilla to restart active growth phase. GHK-Cu (copper tripeptide) stimulates VEGF production — the follicular vascularization factor — and activates the dermal growth factor pathway.

Application is non-negotiable: dry scalp, morning and evening, minimum 60-second massage. Peptides act on the next hair cycle. First vellus hairs (translucent fuzz) typically appear at month 4-5. Visual density gain on photos arrives between months 7 and 9.

Alongside, I systematically add scalp massage — not with just any brush, but with a soft silicone massage brush that mechanically stimulates the dermal papilla without risk of micro-trauma. The Japanese study Koyama et al. (2016, Eplasty) documented a significant gain in follicular thickness in men with early alopecia after 24 weeks of 4-minute daily manual massage. The mechanism is mechanical: stretching of dermal papilla cells, which activates the growth factor signaling pathway.

Phase 3: Months 9-12 — Consolidation and relapse prevention

Once shedding has stopped and density has visibly recovered, the classic mistake is to drop everything. But CTE has a strong tendency to relapse if the biological terrain deteriorates again. This phase is consolidation: maintain minimal supplementation (iron if needed, vitamin D year-round), space the multi-peptide serum to 3 applications per week, and install the right reflexes for the years to come.

One often-overlooked detail: the silk pillowcase. On hair that has lived through a CTE, the fiber is fragile. Friction on cotton overnight (6 to 8 hours) creates micro-cracks that visually amplify the perceived density loss. 22-momme natural silk eliminates that friction.

💡 Expert advice from Elena S.: “Sophie, the architect patient from the beginning, came back at 9 months into the protocol. She placed a new photo on my desk — the same position as the previous 18. Her part had closed. Her ponytail had regained normal volume. She said: ‘I didn’t think this was possible.’ I told her it wasn’t a miracle — it was just the right panel, the right corrections, the right patience. Follicular biology never lies when you give it what it asks for.”

FAQ — Your frequent questions on chronic telogen effluvium

How long does chronic telogen effluvium last untreated?

That’s precisely the definition of CTE: shedding persists beyond 6 months with no spontaneous tendency to resolve. In Sinclair’s follow-up studies (2002), untreated cases lasted 3 to 7 years before spontaneous stabilization — with a global density loss of roughly 30 to 40%. It’s precisely to avoid this slow erosion that I recommend an active protocol starting at month 6, even though CTE remains “biologically” reversible.

---

My bloodwork is “normal” yet I keep shedding. What now?

The most common situation I see. In 90% of cases, it’s because the bloodwork was read with lab thresholds, not capillary thresholds. A ferritin of 35 is “normal” for the lab but deficient for the follicle. Ask to see your numbers, compare them to the thresholds I list in the bloodwork section above, and if everything is genuinely optimal — then explore other angles (chronic stress, medication, post-viral, early FPHL). A consultation with a trichology-specialized dermatologist with trichoscopy will settle it.

---

How long before I see results from the multi-peptide serum?

The follicle works in biological cycles of 12 to 16 weeks for the initial anagen phase. You cannot see biological effect before 3 months — it’s mechanically impossible. The classic milestones: month 3 (vellus hairs visible on the hairline and crown), month 5 (denser feel to the touch, daily shedding diminished), months 7 to 9 (measurable visual gain on before/after photos under the same lighting), month 12 (density consolidation). Any patient who stops at 6 weeks has underestimated follicular biology.

---

Can I take iron without prior testing?

No, and it’s dangerous. Iron overload (hemochromatosis or acquired hyperferritinemia) affects about 1 in 200 women and can be worsened by blind supplementation. Always test ferritin + transferrin saturation coefficient + CRP before any iron supplementation. If ferritin > 100 ng/mL, no supplementation — your shedding has another cause.

---

Can chronic telogen effluvium evolve into FPHL?

Not mechanically, no. CTE and FPHL are distinct pathologies. But it happens that an early FPHL is masked by a CTE declaring itself first — diffuse shedding hiding the localized crown miniaturization. When CTE resolves under protocol, the underlying FPHL can then become visible. That’s why a trichology dermatologist with trichoscopy is crucial in situations persisting beyond 12 months on a well-conducted treatment. For women discovering an androgenetic hormonal component, also read our guide on menopause hair loss treatment which covers anti-androgenic protocols.

---

Difference between telogen effluvium and alopecia?

Alopecia is a generic term for any hair loss. Telogen effluvium is a specific type of alopecia characterized by diffuse non-scarring shedding, where the follicle stays alive and functional — only the hair cycle is disrupted. Unlike androgenetic alopecia (where the follicle shrinks and dies) or scarring alopecia (where it’s destroyed by inflammation), telogen effluvium is by definition reversible. That reversibility is what makes it the most optimistic form to diagnose — provided the diagnosis is made correctly, which this article gives you the tools to do.

Sources and Clinical Studies

1. Whiting DA. — Chronic telogen effluvium: increased scalp hair shedding in middle-aged women, J Am Acad Dermatol, 1996; 35(6): 899–906. PubMed

2. Sinclair R. — Chronic telogen effluvium: a study of 5 patients over 7 years, J Am Acad Dermatol, 2005; 52(2 Suppl 1): 12–16. PubMed

3. Trost LB, Bergfeld WF, Calogeras E. — The diagnosis and treatment of iron deficiency and its potential relationship to hair loss, J Am Acad Dermatol, 2006; 54(5): 824–844. PubMed

4. Rasheed H, Mahgoub D, Hegazy R, et al. — Serum ferritin and vitamin D in female hair loss: do they play a role?, Skin Pharmacol Physiol, 2013; 26(2): 101–107. PubMed

---

Medically reviewed by our internal panel of dermatology experts. This article is informational and does not replace medical consultation. In case of shedding persisting beyond 12 months on a rigorous protocol, consult a trichology-specialized dermatologist for confirmatory trichoscopy.